Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-08 · accession 0001801170-25-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-11 | 2025-02-08 | CLOV | Toy Andrew | CEO, Dir | F - Tax | $4.32 | -85.5K | 11.26M | -0.8% | -$369.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-08 | F | D | 85,535 | $4.32 | 11,263,482 | D | — | — | (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. |